One of the main brands of adrenaline auto-injector pen, which can save lives during serious allergy attacks, is being recalled in the UK after the death of a teenager whose family say the product failed.
Shante Turay-Thomas, 18, died in September last year after it is claimed that her adrenaline pen did not work although she tried it twice. She told her mother, “I’m going to die,” as she succumbed to an allergic reaction to hazelnuts. Her death was the subject of an inquest hearing last month, which resumes this week.
The Medicines and Healthcare products Regulatory Agency (MHRA) confirmed this weekend that all batches of Emerade auto-injector had been recalled from pharmacies after an error was identified that can cause some pens to fail to activate. Between July and November, the agency said it had been made aware of 16 suspected activation failures. The agency said it was aware of two fatalities of patients reported to have used the pens but the fault had not been confirmed as a contributor to the deaths.
Read full story
Source: The Times, 8 December 2019